Proteomic Analysis of Retinas from Two Different Type-1 Diabetic Models
Biomolecules · 2026
DOI: 10.3390/biom16091314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Gieth Alahdab und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center, Oakland University William Beaumont School of Medicine (OUWB-SOM), Rochester, MI 48309, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Proteomics, Retina, Diabetic Retinopathy. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
This study investigated retinal proteomic alterations associated with type-1 diabetes mellitus (T1DM) using two mouse models of diabetic retinopathy (DR): the genetic Ins2akita/+ (Akita) model and streptozotocin (STZ)-induced diabetes. Retinas were collected from Akita (n = 4) and STZ-induced diabetic mice (n = 6) 15–16 weeks after the onset of diabetes and compared with age-matched controls. Quantitative mass spectrometry identified 7933 proteins in Akita retinas and 7399 proteins in STZ retinas. Differentially expressed proteins were identified using adjusted p-values and log2 fold-change, ranked by Manhattan distance, and visualized with volcano plots and heatmaps. The top 20 dysregulated proteins in each model were subjected to canonical pathway analysis. Both models demonstrated upregulation of inflammatory and angiogenesis-associated proteins, including LRRC58, coronin-2A, S100-A4, and COL4A2, supporting a pro-inflammatory and vascular remodeling microenvironment. However, several protein changes differed between the two models. For example, Crystallins were downregulated in the STZ model but upregulated in the Akita model, which were validated by western blot analysis. Canonical pathway analysis revealed activation of platelet-related signaling pathways, enrichment of lipid metabolic networks, and significant alterations in extracellular matrix organization. These findings indicate coordinated inflammatory, metabolic, and structural remodeling in DR and identify candidate molecular pathways for further investigation and therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Research Center, Oakland University William Beaumont School of Medicine (OUWB-SOM), Rochester, MI 48309, USA.
- Eye Research Institute, Oakland University, Rochester, MI 48309, USA.
- Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.
- Department of Biomedical Sciences, College of Medicine, Dubai Medical University, Dubai P.O. Box 20170, United Arab Emirates.
- Foundational Medical Studies, Oakland University William Beaumont School of Medicine (OUWB-SOM), Rochester, MI 48309, USA.
ORCID-Profile: Sonali Sharma, Muhammad N Haque, Khaled Elmasry, Mohamed Al-Shabrawey
Förderung
- NIEHS NIH HHS
- NIH HHS
- NCI NIH HHS
- NEI NIH HHS
- NIH/National Eye Institute
Zitieren
APA
Alahdab, G., Sharma, S., Koneru, N., Moustafa, M., Haque, M. N., Lowran, K., Zhang, X., Ahmed, S., Elmasry, K., & Al-Shabrawey, M. (2026). Proteomic Analysis of Retinas from Two Different Type-1 Diabetic Models. Biomolecules. https://doi.org/10.3390/biom16091314
Vancouver
Alahdab G, Sharma S, Koneru N, Moustafa M, Haque MN, Lowran K, et al. Proteomic Analysis of Retinas from Two Different Type-1 Diabetic Models. Biomolecules. 2026. doi:10.3390/biom16091314
BibTeX
@article{Alahdab2026,
author = {Alahdab, Gieth and Sharma, Sonali and Koneru, Nandini and Moustafa, Mohamed and Haque, Muhammad N and Lowran, Kaitlin and Zhang, Xiao and Ahmed, Shether and Elmasry, Khaled and Al-Shabrawey, Mohamed},
title = {Proteomic Analysis of Retinas from Two Different Type-1 Diabetic Models},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091314}
}
EUVIMED